GRDX earnings date and last-quarter result: next report 2026-08-17, last quarter beat, P/E -0.73. Updated 2026-07-23.
GridAI Technologies (GRDX) Research Hub
GridAI Technologies (GRDX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 5.55 USD (-0.98%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.73, market cap 0.01B. This hub links to the full technical, earnings and options research available for GRDX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.55 USD (-0.98%) |
| 52-week range | 2.56 USD – 5.71 USD |
| Trend regime | Range |
| 14-day RSI | 69.7 (Bullish) |
| Trailing P/E | -0.73 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-17 |
Available research for GRDX
Covered Call on GRDX: how it works, illustrative setup around the real 5.55 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GRDX: how it works, illustrative setup around the real 5.55 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GRDX: how it works, illustrative setup around the real 5.55 USD price, max profit/loss, breakeven and when to use it. Educational.
GRDX technical analysis: range, last 5.55 USD, RSI 69.7, 52w range 2.56 USD–5.71 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GRDX in?
GridAI Technologies (GRDX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is GRDX in an uptrend or downtrend?
As of 2026-10-26, GRDX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GRDX's trailing P/E ratio?
GRDX's trailing P/E is -0.73, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does GRDX next report earnings?
GRDX is next scheduled to report earnings on 2026-08-17.